drugset
drugset / Trial / NCT04094805

A Multicenter Randomized Study of Vitamin D Combined With HD-DXM Versus HD-DXM for the Treatment of ITP

NCT04094805 ↗

Phase 4 Unknown 60 enrolled Shandong University
RandomizedParallel-groupOpen-labelTreatment

Summary

The project was undertaking by Qilu Hospital of Shandong University in China. In order to report the efficacy and safety of vitamin D combining with high-dose dexamethasone for the treatment of adults with newly-diagnosed primary immune thrombocytopenia (ITP).

Timeline

Start
2020-10-01
Primary completion
2021-03-01
Completion
2021-10-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcitriol Small molecule 0.25 ug Oral
Comparator Dexamethasone Small molecule 40 mg Oral

Indications

autoimmune thrombocytopenia